Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2013

View Archived Issues

Roche presents highlights of second quarter 2013

Kalydeco beneficial in patients with cystic fibrosis and non-G551D gating mutations

EMA's CHMP issues positive opinion regarding afatinib

FDA lifts clinical hold on Cangene's recombinant factor IX product candidate

FDA grants orphan drug status to Convergence Pharmaceuticals' CNV-1014802

Depomed acquires Lazanda nasal spray

Anacor Pharmaceuticals submits NDA to the FDA for tavaborole

Kolltan in-licenses antibody targeting HER3

AbbVie reports key pipeline events of second quarter 2013

FDA accepts tasimelteon NDA for priority review

Noxxon Pharma patents new nucleic acid molecules

MK-8931 leads to reductions in brain amyloid levels in patients with Alzheimer's disease

Researchers at Nippon Chemiphar present novel P2X4 receptor antagonists

Acetylon Pharmaceuticals and Celgene to advance several HDAC inhibitors

Ref Pharma presents new agents for HCV infection

Scientists at ACEA Biosciences divulge new agents for cancer

Wellcome Trust grants award to GlycoVaxyn for Shigella program

Clinical evaluation of a novel prophylactic therapy for patients with hemophilia B

FDA grants priority review to NDA for MNK-795

U.S. university researchers patent new M1 receptor modulators

Evaluation of a glycoPEGylated recombinant coagulation factor for the treatment of hemophilia

BIND Therapeutics begins dosing in phase II trial in NSCLC

The development of a novel mouse model for Pick's disease

Perrigo enters definitive agreement to acquire Elan

European Commission grants orphan drug designation to BrainStorm's cell therapy for ALS

Novartis receives positive CHMP opinion for Ilaris in systemic juvenile idiopathic arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...